RETRACTED: DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression
A Retraction of the Original Research Article
DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression
by Chen Y, Wang Q, Wang Q, Liu J, Jiang X, Zhang Y, Liu Y, Zhou F and Liu H (2019) Front. Pharmacol. 9:1558. doi: 10.3389/fphar.2018.01558
Following publication, concerns were raised regarding the scientific validity of the article. An investigation was therefore conducted in accordance with our established procedures. As the raw data presented in the manuscript could not be provided, the Specialty Chief Editor concluded that the conclusions and assertions could not be sufficiently supported by the material provided.
The retraction of the article was approved by the Chief Editors of Pharmacology and the Editor-in-Chief of Frontiers.
The authors agree to the retraction.
Keywords:
Citation: Frontiers Editorial Office (2019) Retraction: DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression. Front. Pharmacol. 10:1657. doi: 10.3389/fphar.2019.01657
Received: 17 December 2019; Accepted: 17 December 2019;
Published: 23 December 2019.
Approved by: Salvatore Salomone, University of Catania, Italy
Copyright © 2019 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=